Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

Presentation TCT 2025

TCT 595: Cardiac Damage Staging in Moderate or Greater Aortic Regurgitation: A New Framework for Risk Stratification

Presenter: Francisco Alexandrino

October 27, 2025

Presentation NY Valves 2025

Impact of Prior History of Hospitalization for Heart Failure on Clinical Outcomes After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Ogechukwu Samuel Obi

June 26, 2025

Presentation NY Valves 2025

Impact of Cardiac Damage Staging in Patients With Moderate Aortic Stenosis and Reduced Left Ventricular Ejection Fraction: Insights From the TAVR UNLOAD Trial

Presenter: Yukari Kobayashi

June 26, 2025

Presentation NY Valves 2025

Transcatheter Aortic Valve Replacement in Systolic Heart Failure and Moderate Aortic Stenosis: Ischemic vs. Non-Ischemic Cardiomyopathy – Insights From the TAVR UNLOAD Trial

Presenter: Philipp von Stein

June 26, 2025

Presentation NY Valves 2025

Clinical Impact of Cardiac Damage Across the Spectrum of Severity in Aortic Stenosis Patients

Presenter: Augustin Coisne

June 26, 2025

Presentation TCT 2024

Keynote Lecture I: Rationale for Earlier Intervention in Aortic Stenosis: The Cardiac Damage Concept and Beyond

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 643: Cost Associated With the Extent of Cardiac Damage After Aortic Valve Replacement

Presenter: Philippe Genereux

October 29, 2024

Presentation NY Valves 2024

Updates on Randomized Trials in Moderate AS

Presenter: Sammy Elmariah

June 06, 2024

Presentation NY Valves 2024

The Clinical Impact of Moderate AS

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

Asymptomatic Severe AS – A Clinician’s Perspective

Presenter: Robert O. Bonow

June 06, 2024

Presentation NY Valves 2024

The Cardiac Damage Paradigm to Finetune theTiming of Aortic Valve Replacement

Presenter: Philippe Genereux

June 06, 2024

Presentation NY Valves 2024

Prognostic Value of End-Organ Damage in Patients Undergoing Transcatheter Tricuspid Valve Edge-to-Edge Repair

Presenter: Thomas Stocker

June 05, 2024

Presentation ACC 2024

PROACT: Can we prevent chemotherapy-related heart damage in patients with breast cancer and lymphoma?

Presenter: David Austin

April 08, 2024

Presentation TCT 2023

TCT 496: Artificial Intelligence-Enabled Phenotyping of Patients with Severe Mitral Regurgitation: on the Recovery of Extra-Mitral Valve Cardiac Damage after Transcatheter Edge-to-Edge Repair

Presenter: Elena Rippen

October 26, 2023

Presentation TCT 2023

TCT 54: Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Daijiro Tomii

October 26, 2023

Presentation TCT 2023

TCT 331: Cardiac Damage Staging Predicts Outcomes in Symptomatic and Asymptomatic Aortic Valve Stenosis after Aortic Valve Replacement: Meta-Analysis of Reconstructed Time-to-Event Data

Presenter: Omar Abdelfattah

October 26, 2023

Presentation TCT 2023

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

Presenter: Josep Rodés-Cabau

October 24, 2023

Presentation TCT 2023

Moderate AS With Cardiac Damage: The PROGRESS Trial

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2022

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Presenter: Philippe Genereux

September 18, 2022

Presentation TVT 2022

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Presenter: Philippe Genereux

June 08, 2022

Advertisement

TCT 595: Cardiac Damage Staging in Moderate or Greater Aortic Regurgitation: A New Framework for Risk Stratification

Impact of Prior History of Hospitalization for Heart Failure on Clinical Outcomes After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Impact of Cardiac Damage Staging in Patients With Moderate Aortic Stenosis and Reduced Left Ventricular Ejection Fraction: Insights From the TAVR UNLOAD Trial

Transcatheter Aortic Valve Replacement in Systolic Heart Failure and Moderate Aortic Stenosis: Ischemic vs. Non-Ischemic Cardiomyopathy – Insights From the TAVR UNLOAD Trial

Clinical Impact of Cardiac Damage Across the Spectrum of Severity in Aortic Stenosis Patients

Keynote Lecture I: Rationale for Earlier Intervention in Aortic Stenosis: The Cardiac Damage Concept and Beyond

TCT 643: Cost Associated With the Extent of Cardiac Damage After Aortic Valve Replacement

Updates on Randomized Trials in Moderate AS

The Clinical Impact of Moderate AS

Asymptomatic Severe AS – A Clinician’s Perspective

The Cardiac Damage Paradigm to Finetune theTiming of Aortic Valve Replacement

Prognostic Value of End-Organ Damage in Patients Undergoing Transcatheter Tricuspid Valve Edge-to-Edge Repair

PROACT: Can we prevent chemotherapy-related heart damage in patients with breast cancer and lymphoma?

TCT 496: Artificial Intelligence-Enabled Phenotyping of Patients with Severe Mitral Regurgitation: on the Recovery of Extra-Mitral Valve Cardiac Damage after Transcatheter Edge-to-Edge Repair

TCT 54: Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Undergoing Transcatheter Aortic Valve Replacement

TCT 331: Cardiac Damage Staging Predicts Outcomes in Symptomatic and Asymptomatic Aortic Valve Stenosis after Aortic Valve Replacement: Meta-Analysis of Reconstructed Time-to-Event Data

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

Moderate AS With Cardiac Damage: The PROGRESS Trial

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content